RA CAPITAL MANAGEMENT, L.P.

Holdings History for Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR)

Symbol: MNPR on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 667,632 shares
Security Ownership %: 9.9%

Shares, Excluding Options vs Price

Value, Excluding Options

RA Capital Management, L.P. ownership in Monopar Therapeutics Common Stock, par value $0.001 per share (MNPR)

17 Feb 2026 - RA Capital Management, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 667,632 shares of Monopar Therapeutics Common Stock, par value $0.001 per share (MNPR). This represents 9.9% ownership of the company. In their previous filing dated 14 Nov 2025, RA CAPITAL MANAGEMENT, L.P. had reported owning 742,861 shares, indicating a decrease of +10%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
RA Capital Management, L.P.	9.9%	0%	$43,402,756	667,632	-75,229	-10%	$65.01	13G/A	31 Dec 2025	17 Feb 2026, 16:37
RA Capital Management, L.P.	9.9%	0%	$60,669,086	742,861	+122,745	+20%	$81.67	13G/A	30 Sep 2025	14 Nov 2025, 16:16
RA Capital Management, L.P.	9.9%		$27,638,570	620,116			$44.57	13G/A	31 Dec 2024	14 Feb 2025, 18:25

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.45%	+0.1%	$43,568,617	667,207	+156,000	+31%	$65.30	Q4 2025
30 Sep 2025	0.51%	0%	$41,750,276	511,207	0		$81.67	Q3 2025
30 Jun 2025	0.31%	0%	$18,290,986	511,207	0		$35.78	Q2 2025
31 Mar 2025	0.31%	0%	$18,613,047	511,207	0		$36.41	Q1 2025
31 Dec 2024	0.15%	+0.15%	$11,246,554	511,207	+511,207	NEW	$22.00	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.